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Summary 
Induced activation of protein tyrosine kinase(s) is a central event in signal transduction mediated 
via the low affinity receptor for IgG (Fc3`RIIIA, CD16) in natural killer (NK) cells. Tyrosine 
phosphorylation may affect the function of several proteins  directly, or indirectly by inducing 
their association with other tyrosine phosphorylated proteins.  Here, we report that FcTRIII 
stimulation induces activation of phosphatidylinositol  (PI)-3 kinase in NK cells. Phosphotyrosine 
immunoprecipitates from FcTRIII-stimulated  NK cells contain PI-kinase activity and PI-3 kinase 
can be directly precipitated from them. Conversely, a series of tyrosine-phosphorylated  proteins 
is coprecipitated with PI-3 kinase from the stimulated,  but not from control cells. Analogous 
results obtained using Jurkat T ceUs expressing transfected Fc3'RIIIAol ligand binding chain in 
association  with 3'2  or  ('2  homodimers indicate  that  both  complexes  transduce  this  effect, 
although the FcTRIIIA-~'2 complexes do so with greater efficiency. Accumulation of phospho- 
inositide D3 phosphorylated products in stimulated ceUs  confirms PI-3 kinase activation, indicating 
the participation  of this enzyme in FcTRIIIA-mediated signal transduction. 
I 
nduced phosphorylation of several proteins  on tyrosine 
residues is the earliest biochemical event detectable in NK 
cells upon binding of ligands to the low affinity receptor for 
the Fc fragment of complexed IgG (Fc3`RIII, CD16) (1-4). 
This is an obligatory event in the receptor-indueed signal trans- 
duction, leading to phospholipase C (PI.C)1-3`1 and -3`2 ac- 
tivation, phosphatidylinositol (PI) hydrolysis, and subsequent 
increase in the intracellular Ca  2  + concentration ([Ca  2  +  ]i) and 
to the more distal events including cytotoxidty, synthesis of 
cytokines, and expression of IL-2 receptor o~ chain and other 
surface  activation  antigens  (3-7).  The  Fc3`RIIIA  ligand 
binding c~ chain and its associated 3' and ~" chains necessary 
for  its  membrane expression  (8)  and  signal  transduction 
(9-11) are devoid of kinase domains (12-14) and intrinsic kinase 
activity, and tyrosine phosphorylation occurs via activation 
of the src-related kinase p56 kl,  physically associated with 
FcyRIIIA in NK cells via its interaction with the two chains, 
upon Fc3,RIIIA-ligand  binding (4,  15). 
Ligand binding to receptors endowed with intrinsic tyro- 
sine kinase activity, or associated with intracellular tyrosine 
1 Abbreviations used in  this paper: ARH,  antigen receptor homology; 
[Ca2+]i ,  intraceUular Ca  2+ concentration; GaMIg, goat anti-mouse Ig; 
PI,  phosphatidylinositide; PIP, phosphatidylinositol phosphate; PKC, 
protein kinase C; PLC, phospholipase C; SH, src homology. 
kinases, has been shown to induce activation of PI-3 kinase. 
This enzyme consists of a 110-kD catalytic and an 85-kD 
regulatory subunit (16, 17) that, through its src homology 
2 (SH2) domains, can associate  with specific  phosphotyrosine- 
containing domains (YMXM) in other proteins  (18). This 
association is one of the mechanisms leading to functional 
activation of the enzyme; association of the p85-kD subunit 
with the platelet-derived growth factor (PDGF) receptor is 
essential for the PDGF-induced mitogenic signal (19). The 
110-kD PI-3  kinase subunit has been shown to be phos- 
phorylated and to associate with the polyoma middle T-acti- 
vated p60  ~ in vitro (20), and the p85-kD regulatory subunit 
of PI-3 kinase is phosphorylated on tyrosine residues upon 
stimulation of various receptors  (21, 22). Phosphorylation 
of either subunit, however, does not seem to be essential for 
the activation of the enzyme. PI-3 kinase catalyzes phosphory- 
lation of the inositol ring of PI, PI-4-P, and PI-4,5-P2 at the 
D-3 position, resulting in formation of PI-3-P, PI-3,4-P2, 
and  PI-3,4,5-P3  (23). These  lipids  are  not  substrates  for 
known phospholipases. PI-3,4,5-P3 has been reported to ac- 
tivate protein kinase C (PKC) ~" isozyme (24), and a role for 
this product in the interaction with cytoskeleton-associated 
proteins leading to alteration of cellular structures has been 
proposed (25), whereas targets for the other lipids have not 
been identified. PI-4 and PI-4-P5 kinase activities associated 
with the tyrosine phosphorylated proteins precipitated from 
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tected (26).  One of their products, PI-4,5-P~, is a substrate 
for hydrolysis by PLC-3' leading to the synthesis of second 
messengers  in receptor=dependent  signal transduction (27). 
Except for p56 ~  (15),  PLC-'y1  and PLC-3,2  (4,  7),  and 
the 3' and ~" chains (1, 2, 28), the identity of other proteins, 
either tyrosine-phosphorylated or associated with phospho- 
proteins, and their possible  role in signal transduction via 
FeyRIIIA in NK ceils has not been established. In this manu- 
script, we report that Fe'/RIIIA-ligand interaction in human 
NK cells and in T cells expressing  FeyRIIIAo~ chain in as- 
sociation with 3, or ~" chain induces activation of PI-3 kinase 
via its association to a number of tyrosine phosphorylated 
proteins, in the absence of detectable phosphorylation on tyro- 
sine residues of the p85-kD regulatory subunit of the kinase. 
Stimulation of Fcq,  RIIIA-transfected cells with anti-CD16 
mAb also results in accumulation of D3-phosphoinositides, 
confirming that PI-3 kinase activation occurs upon ligand 
binding to Fc3,KIIIA. 
Materials and Methods 
Cell Lines.  The human B lymphoblastoid RPMI 8866 and the 
murine mAb producing cell lines were maintained in culture in 
KPMI 1640 (Flow Laboratories,  Malvern, PA) supplemented with 
10% heat-inactivated  FCS (Sigma Chemical Co., St. Louis, MO). 
FeyRIIIAc~-transfected  CD3-/CD2- J32.65.3.1 Jurkat T cells ex- 
pressing Fc3'RIIIA in association with endogenous ~" chain, and 
FeyKIIIB-transfected  CD3 +/CD2 + J32.10 ceils were produced in 
our laboratory (4); the FeyRIIIAc~  + FceKIq,-transfected  CD3 §  / 
CD2 + Jurkat cells, expressing FeyRIIIAc~  in association with 3'2 
homodimers, were a kind gift of  Dr. J. V. Ravetch  (Memorial  Sloan 
Kettering Cancer Institute, New York) (11). The transfected cells 
were maintained in culture in RPMI 1640 supplemented  with 10% 
heat-inactivated  protein G-absorbed FBS and geneticin (G418; Gibco 
Laboratories, Grand  Island, NY).  All  cell lines were free of 
mycoplasma contamination. 
mAbs, Polyclonal Sera, and Reagents.  Production and character- 
ization of mAb 3G8 and B73.1 (anti-CD16, IgG1), B36.1 (anti- 
CDS,  IgGzb), OKT3  (anti-CD3,  IgGz~), B159.5 (anti-CD56, 
IgG1), and B52.1 (anti-CD14, IgM) have been previously  reported 
(29). Anti-phosphotyrosine mAb 1G2 was obtained from hybrid 
cells kindly provided  by Dr. R. Frackeldon  (Brown  University,  Provi- 
dence, ILl) through the American Type  Culture Collection (Rock- 
ville, MD). The goat anti-mouse Ig (GaMIg) used to prepare sheep 
E for indirect antiglobulin  rosetting and for cross-linking  cell  surface- 
bound mAbs was produced in our laboratory, absorbed on human 
Ig, and affinity-purified  on mouse IgG-Sepharose  4B column (Phar- 
macia Fine Chemicals, Uppsala, Sweden). The polyclonal rabbit 
sera anti-phosphotyrosine  and anti-p85 subunit of PI-3 kinase were 
purchased from ICN Biomedicals,  Inc. (Costa Mesa, CA) and Up- 
state Biotechnology Inc. (Lake Placid, NY), respectively. PI was 
from Avanti Polar Lipids Inc. (Birmingham, AL); orthophenyl- 
phosphate and adenosine were from Sigma Chemical Co. 
NK CelIPre~rations.  PBMC were separated  on Ficoll/Hypaque 
density gradient (Lymphoprep;  Nyegaard  Co., Oslo, Norway) from 
venous blood of healthy individuals. The majority of monocytes 
were depleted after adherence to plastics (45 rain, 37~  Homo- 
geneous NK cell preparations were obtained by negative selection 
from short term (10 d) co-cuhures of PBL with 30-Gy-irradiated 
RPMI 8866 cells using a mixture of anti-CD14, anti-CD3,  and 
anti-CD5 mAb and indirect antiglobulin rosetting (29). The pu- 
rity of these preparations was always >95%, as tested in indirect 
immunofluorescence  with a panel of  mAb and human Ig-absorbed 
FITC-conjugated  goat F(ab')2 anti-mouse Ig (Cappel Laboratories, 
Cochranville, PA) using a Profile II flow cytofluorimeter (Coulter, 
Hiahah, FL). 
Cell Stimulation.  The different  cell types were washed  in serum- 
free RPMI and resuspended in the same medium (107 cells/m1). 
The indicated mAbs (ascites, 10 -3 dilution) were added, and the 
ceils were incubated for various periods of time at 37~  in the ab- 
sence or presence of GaMIg (10 #g/ml). 
Immunoprecipitation and  Western Blotting.  After the indicated 
treatments, the cells were sohbilized with lysis buffer (10 mM 
Hepes, pH 7.5, 0.15 mM NaCI,  10% glycerol, 10 #g/ml each 
leupeptin and aprotinin,  1 mM PMSF, I  mM NaVO,, and 1% 
NP-40). Postnuclear supernatants were precleared (2 h, 4~  with 
preimmune  rabbit serum  coupled  to Protein A-Sepharose  (LKB  Phar- 
macia). The indicated antibodies coupled to Protein A-Sepharose 
were used for immunoprecipitation (2 h, 4~  The precipitates 
were washed  twice with lysis  buffer,  and twice with 0.15 mM NaC1, 
10 mM Hepes, and 0.2% NP-40. After elution in sample buffer, 
the proteins were separated on 7.5% SDS-PAGE under reducing 
conditions and transferred  to nitrocellulose  filters (MSI, Westboro, 
MA). These were saturated with 0.5% gelatin in 'Iris buffered sa- 
line (TBS) and incubated (12-16 h, 4~  with the indicated anti- 
bodies at predetermined optimal concentrations. After five  washes 
in TBS containing 0.25% Tween-20 and 0.25% NP-40, antibody- 
reactive proteins were detected using either IzsI-Protein A (ICN 
Biomedicals, Inc.) and autoradiography, or horseradish peroxidase 
(HRP)-labeled sheep anti-rabbit serum and enhanced chemilumi- 
nescence (ECL; Amersham Corp.,  Arlington  Heights,  IL) (4). 
When indicated, the filters were stripped (30 min, room tempera- 
ture, 0.1 M glycine/HC1, pH 2.6) and reprobed with the indicated 
antibody. 
PI Kinase Assays.  These were performed on the material im- 
munoprecipitated, as above, from the indicated cells using afl~ity- 
purified  1G2  anti-phosphotyrosine  mAb  coupled  to  Protein 
A-Sepharose via rabbit anti-mouse Ig. The immunoprecipitates  were 
washed twice with lysis buffer, once with 20 mM Hepes, 0.5 M 
LiC1, and twice each with 0.15 M NaC1, 10 mM Hepes with and 
without 0.2% NP-40. Tyrosine  phosphoryhted proteins were eluted 
from the beads using 40 mM orthophenylphosphate in 30 mM 
Hepes, pH 7.5. PI kinase activity in the eluate (30/~1) was assayed 
using 0.2 mg/ml PI in the presence of 40 #M ATP, 10 #Ci .y.[32p] 
ATP (4,500 Ci/mmol sp. act; ICN), with and without added aden- 
osine, 200 #M, or NP-40, 0.5%, for 15 min at room temperature. 
The reaction was stopped with 100 #1 1 N HC1, and the lipids 
were extracted  with 200 #1 chloroform/methanol (1:1, vol/vol) mix- 
ture. After washing once with methanol/1 N HC1 (1:1, vol/vol), 
lipids in the organic phase were separated by TIC on silica gel G 
60 sheets (J. T. Baker Inc., Phillipsburg, NJ). The TIC was devel- 
oped in chloroform/methanol/H20/NH(OH  (43:38:7:5, vol/vol). 
Radioactive PIP products were visualized by autoradiography. 
Detection of  Potyf,  hosphoinositides  Accumulation in Intact Cells.  The 
indicated cells were washed in phosphate- or inositol-free KPMI 
1640, as appropriate, supplemented with 1% dialyzed FBS and in- 
cubated (10 7 cells/m1, 3 h, or 2  x  106 cells, 20 h, 37~  in the 
same medium in the presence of 200 #Ci/ml [32p]H3PO4 (sp. act 
285 Ci/mg P; ICN Biomedicals, Inc.) or 20 #Ci/ml [3H]myo- 
inositol  (sp. act 18.7 Ci/mmol; Amersham  Corp.), respectively.  After 
washing, the cells were stimulated with the indicated mAbs as de- 
scribed above; the lipids were extracted with 1 N  HC1/chloro- 
form/methanol (1:2:1, vol/vol), and D-3 polyphosphoinositides  were 
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scribed (23). 
Results 
Activation of PI Kinase upon FcTRIII Stimulation.  PI ki- 
nase was measured in the orthophenylphosphate  ehate of anti- 
phosphotyrosine (1G2 mAb) immunoprecipitates  from post- 
nuclear lysates of NK ceUs and of Fc3,RIII-transfected Jurkat 
T cells, treated or not with anti-CD16 mAb. Minimal kinase 
activity was detected in the immunoprecipitates  from lysates 
of NK  cells  and  of three different types  of transf~ctants 
(Fc'gKIIIAo~/3% Fc3,RIIIAod~'2, and Fc3,KIIIB) in the ab- 
sence of stimulation or after treatment with control anti-CD56 
mAb (Fig. 1). Significant kinase activity was instead detected 
in those from NK cells and from both types of Fc3,KIIIA-, 
but not Fc3,RIIIB-transfected  Jurkat T cells treated with mAbs 
directed to two different Fc3,KIII epitopes, 3G8 (Fig. 1), and 
B73.1 (not shown), and GaMIg for 5 min. On the basis of 
densitometric  measurements, the activity detected upon CD16 
stimulation in NK calls and in Fc3'RIIIAod3,2  transfectants 
was, on average, fourfold that in control antibody-treated cells, 
and  approximately ninefold lower  than  that  detected  in 
Fc3'KIIIAcff~'2 transfectants.  Phosphotyrosine precipitates 
from anti-CD3 mAb-treated CD3 + Jurkat cells transfected 
with Fc3~RIIIAo~/3~2  (Fig.  1), but not those from similarly 
treated NK cells or CD3-  Jurkat cells expressing Fc3~RI- 
IIAod~'2 (not shown), contained kinase activity: this was ap- 
proximately threefold greater than that detected upon CD16 
stimulation in the same cells, as determined  by densitometry. 
PIP production was detectable in the anti-phosphotyrosine 
immunoprecipitates from NK cells treated with anti-CD16 
mAb for as short as 10 s (not shown), was maximal at  1 
and 5 min, and declined afterwards; lower PIP amounts were 
detected, with similar kinetics,  when anti-CD16 mAb was 
Figure 2.  Kinetics of Pc3,KIIl-induced PI-3 kinase activation in NK 
cells. Homogeneous preparations of NK cells were incubated, as in Fig. 
1, with 3G8 mAb, with or without GaMIg added, for the indicated times. 
PI-3 kinase assays were performed in the presence of adenosine on the or- 
thopheaylphosphate  duate of 1G2 immunoprecipitates  from the respec- 
tive lysates, under the conditions described in Fig.  1. 
cross-linked with GaMIg (Fig. 2). Similar results were ob- 
tained using Fc3,RIIIAod~'2 transfectants (not shown). 
Identification of PI-3 Kinase in the Anti-phosphot~sine  Im- 
raunoprecipitates upon FcTRIIIA  Stimulation.  PI-3 and PI-4 
kinases differ in sensitivity to detergent and adenosine. De- 
tergents, e.g., NP-40, inhibit PI-3 and stimulate PI-4 kinase, 
whereas adenosine inhibits only the latter (30).  The prod- 
ucts of the PI kinase formed, in the presence or absence of 
adenosine, by anti-phosphotyrosine immunoprecipitate  from 
NK calls treated with anti-CD16 mAb (Fig. 3 A) had similar 
TLC mobility and were produced in comparable amounts, 
as evaluated by densitometric measurements of the film. No 
kinase activity was present, under either condition, in the 
samples from nonstimulated or control mAb-treated cells. 
Upon addition of 0.5% NP-40 to the kinase assay mixture, 
the single PiP product formed in the presence or absence of 
adenosine was no longer detectable;  instead, similar levels 
of a phosphorylated product that,  on TLC, ran ahead of 
that produced in the presence of adenosine were detected in 
Figure 1.  PI kinase activity induced upon Fc3,ILIII  stimulation. Ho- 
mogeneous preparations of NK ceils, CD3 + Jurkat cells expressing trans- 
fected Fc3,RIlIAcx  in association with ?a, or F~RIIIK and CD3- Jurkat 
cells expressing Pc3dLllIAoL  in association with endogenous  ~'z, were in- 
cubated (10  r cells/ml RPMI 1640, 5 rain, 37~  in the absence (none) 
or presence of B159.5 (CD56),  3(;8 (CD16),  OKT3 (CD3) mAb (IgG, 
2 #g/ml) as indicated, and GaMIg (10 #g/ml). Tyrosine phosphorylated 
proteins were immunoprecipitated using 1G2 mAbs. PI kinase assays  were 
performed on the orthophenylphosphate ehate of the immunoprecipitates 
and analyzed in TLC as described in Materials and Methods. The position 
of the PIP product  is indicated. 
Figure 3.  Identification of PI-3 kinase associated with tyrosinr  phos- 
phorylated proteins upon Fc~RIII stimulation. Lysates  from NK cells, in- 
cubated with the indicated mAb, were subjected to anti-phosphotyrosine 
immunoprecipitation, orthophenylphosphate ehtion, and PI kinase assays, 
under the same conditions described in Fig. 1. (,4) PI kinase assays were 
performed on identical aliquots of each sample in the absence (none) or 
presence of adenosine, 200 #M, or NP-40, 0.5%. (B) p85-kD PI-3 kinase 
subunit was immunoprecipitated  from the orthophenylphosphate  duates 
of the 1G2 immunoprecipitates from NK cells treated as indicated. PI ki- 
nase assay was performed on the immunoprecipitates  in the presence of 
adenosine, 200 #M. 
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were obtained using the F~TRJIIAcx/~'2 transfectants  (not 
shown). 
To confirm the presence of PI-3 kinase in the phosphotyro- 
sine immunoprecipitates,  the orthophenylphosphate duates 
derived from the phosphotyrosine immunoprecipitates from 
control or CD16-treated  NK cells  were reimmunoprecipi- 
tated with anti-p85 antiserum and PI kinase assays were per- 
formed on the products of the second precipitation.  PI-3 ki- 
nase activity was detected only in the precipitates from the 
stimulated cells  (Fig.  3 B). 
Polyphosphoinositides Accumulation in CD16-stimulated Cells. 
To determine  whether Fc'yRJIIA-induced  PI-3 kinase acti- 
vation correlates with accumulation of D-3 lipids in intact 
cells, the levels of these products were analyzed in cells meta- 
bolically labded with [3ZP]H3PO4  or [3H]inositol  and treated 
with anti-CD16 and control anti-CD56 mAb in the pres- 
ence of GaMIg for 5 min (Pig.  4).  In the Fc3,KIIIAcx/~'2 
transfectants  (Fig.  4,  top panels) significant  levels  of PI-3, 
4-Pz (panel B) and even higher levels of PI-3,4,5-P3 (panel C) 
accumulated in the CD16-stimulated cells, as compared with 
nontreated  or  control  mAb-treated  cells.  In  the  CD3 + 
Fc'yRJIIAcx/3,2 transfectants both CD16 and CD3 stimula- 
tion (Fig.  4, bottom and middle panels, respectively)  induced 
levels of PI-3,4,5-P3  low, but significantly higher than con- 
trois.  In repeated experiments,  we were unable to  detect 
significant levels of D-3 phosphoinositides in NK cells upon 
treatment with anti-CD16 mAb in the presence or absence 
of GaMIg over a 15-min period  (data not shown). 
Tyrosine Phosphoo/lated Proteins Associated with PI-3 Kinase. 
Detection  of PI-3  kinase  activity  in the phosphotyrosine 
precipitates from F-~:3,RIII-stimulated  cells may depend on its 
induced association  with tyrosine-phosphorylated  proteins 
and/or on phosphorylation on tyrosine residues of either or 
both subunits of the kinase.  To distinguish between these 
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Figure  4.  Fc3,KIIIA-induced accumuh- 
don of polyphosphoinoskides in FcTgIHA- 
transfected Jurkat ceils. FcTKIIIAa/~'2 (top 
pane/s)  and  FcTKIIIAot/3,2  (m/dd/e and 
bottom panels) Jurkat transfectants were in- 
cubated  at  37~  with  [~2p]H3PO4  or 
[3H]myoinositol in phosphate- or inositol- 
free P,.PMI 1640,  1% dialyzed FBS for 3 
and 20 h, respectively.  The metabolically 
labeled cells were washed and incubated (5 
rain, 37~  with: A, 3G8 (CD16) (top and 
middle panels)  or  OKT3  (CD3)  (bottom 
panels),  or  A,  B159.5  (CD56)  (ascites, 
10 -3  final  dilution)  in  the  presence  of 
GaMIg (10/~g/ml). After stimulation, the 
lipids were extracted and analyzed by anion 
exchange chromatography on HPI~, as de. 
scribed in Materials and Methods; x-axis, 
elution time, ),-axis, dpm in the duted frac- 
tions.  The position of 3H-labeled  PI-4-P 
and  PI-4,5-P3  standards  run  on  paralhl 
columns (---) is indicated underneath each 
panel. 
554  Fc tLIIIA-induced  Phosphatidylinositol-3  Kinase  Activation Figure  5.  Tyrosine phosphoryhted 
proteins  associated  with  PI-3  kinase 
upon  FeylLIIIA stimulation. Homo- 
geneous  preparations  of  NK  cells, 
I:~R.IILAod72,  and  Fc~P-,JIIAod~'2 
transfected Jurkat cells were incubated 
with  the  indicated  antibodies  and 
GaMIg as described in Fig. 1. Anti-p85 
rabbit  serum,  or  nonimmune  (n.i.) 
serum as control, were used for immu- 
noprecipitation (/P). The precipitated 
material was subjected  to 7.5% SDS- 
PAGE followed by Western blotting 
with anti-phosphotyrosine  (anti-Fi  r, to/, 
pane/s) and anti-p85 PI-3-kinase subtmit 
rabbit  serum  (bottom  panels)  used  se- 
quentially on the same blots. Reactive 
proteins  were  detected  with  nSl. 
protein  A and autoradiogzaphy.  The  po- 
sition  of molecular  weight  standards  is 
indicated. 
phosphotyrosine antibody on the PI-3 kinase precipitated, 
using an anti-85-kD subunit antibody, from the postnuclear 
lysates of nonstimulated, CD16-, or control CD56-treated 
NK cells (Fig. 5). PI-3 kinase, detected with an anti-85-kD 
subunit antibody after stripping and reblotting the same filter, 
was present at similar levels in all lysates. No tyrosine phos- 
phorylated proteins, nor PI-3 kinase p85-kD subunits, were 
detected in the precipitates  obtained using control nonim- 
mune sera. Minimal traces of tyrosine-phosphorylated pro- 
reins were detected in the precipitates from untreated and con- 
trol anti-CD56-treated  cells, whereas four major tyrosine 
phosphorylated  proteins of 140-135, 110, 95, and 85 kD were 
detected in the PI-3 kinase precipitates  from anti-CD16+ 
GaMIg-treated  NK  cells. In  FcTRIIIAodh  expressing 
Jurkat cells the anti-phosphotyrosine antibody detected two 
proteins of 135 and 100 kD associated with the PI-3 kinase 
p85 subunit only in immunoprecipitates from cells stimu- 
lated with anti-CD16 mAb. In Fc'/RIIIAodTz transfectants, 
a  tyrosine  phosphorylated  doublet  of Mr  135-142  was 
precipitated also from the control cells; this, as well as an 
additional band at 110 kD, appeared hyperphosphoryhted  upon 
stimulation with either anti-FcTRIII or anti-CD3 antibody. 
No tyrosine phosphorylated proteins of 85 kD were detected 
in either cell line. The level of phosphorylation of the p85 
regulatory  subunit  of PI-3  kinase,  analyzed  in  p85  im- 
munopredpitates from 3Zp-labeled NK and FcTRIIIA/~'2- 
transfected cells, was similar, irrespective of cell stimulation 
(data  not shown). 
Discussion 
After ligand binding to Fc'yRIIIA, tyrosine phosphoryla- 
tion of several proteins is induced in NK cells and in Fc3,RIII- 
transfected  T  cell lines  (1, 2).  For some of these proteins, 
namely the tyrosine kinase p56  kk (4,  14) and PLC-71 and 
-72 (4, 7,  15), this results in activation of their enzymatic 
activity. In this manuscript, we present evidence that activa- 
tion of mother enzyme, PI-3 kinase,  is also induced upon 
Fc'yRIII stimulation. Its activation does not correlate with 
phosphorylation on tyrosine residues of its p85-kD regula- 
tory subunit, but corrdates with its induced association  to 
a set of other tyrosine phosphorylated proteins. 
PI-kinase  activity is present in the phosphotyrosine im- 
munoprecipitates from  NK  cells, and  from  Fe~RIIIAot- 
transfected Jurkat T cells, only after their stimulation with 
anti-FeyRIII-specific mAb, indicating that FeyRIII-dependent 
tyrosine phosphorylation affects the activity of the kinase, 
inducing either its phosphorylation or its association  with 
other proteins that are tyrosine phosphoryhted  upon receptor 
stimulation. The identity of the enzyme responsible for this 
activity as PI-3 kinase was established  on the basis of two 
distinct criteria: (a) characteristic inhibition by detergents (NP- 
40) and resistance to adenosine (30), and (b) coprecipitation 
of the activity with PI-3 kinase p85 subunit from the phos- 
photyrosine immunoprecipitates. A PIP product with TLC 
mobility faster than that detected in the presence of adeno- 
sine was produced when the kinase assays were performed 
in the presence of NP-40, suggesting the expected activation 
of PI-4 kinase by the detergent. Although PI-3-P migrates 
more slowly than the other spot in the TLC system we used, 
unambiguous identification of these two lipids by TLC is 
not possible,  and the presence  of minimal levels of PI-4-P 
in the spots detected when PI kinase assays were performed 
in the absence of adenosine can not be excluded.  However, 
the observation that the slower migrating spot completely 
disappears when NP-40 is added to the assay confirms its 
identification as PI-3-P. The data we obtained in T cells upon 
CD3 stimulation are identical to those obtained with NK 
cells upon CD16 stimulation, supporting reports of PI-3 ki- 
nase activation upon CD3 stimulation (31). 
The kinetics of induction of PI-3 kinase activity is fast, 
and similar whether or not Fear is cross-linked at the cell 
membrane, although differences in the levels of the PIP prod- 
ucts were present in the two conditions. In other systems 
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cytoskdeton upon cell stimulation, and the possibility that, 
after cross-linking (and maximal stimulation), at least part 
of the Pl=3 kinase is trapped within the detergent=insoluble 
fraction of the lysate may explain  these results. 
Precipitation of PI=3 kinase from stimulated Fc3`R.III, but 
not control cells, results in coprecipitation of tyrosine phos= 
phorylated proteins, that appear to be at least in part different 
in NK and in the T cell transfectants.  The identity of these 
proteins is unknown at present, and their differences are likely 
to be related to the cell types analyzed.  Two of the proteins 
detected in NK cells have relative  molecular mass corre- 
sponding to that of the PI=3 kinase 85- and 110-kD subunits. 
The p85-kD regnlatory subunit of PI=3 kinase is a known 
substrate for receptor and nonreceptor protein tyrosine kinases 
(20, 34-37). The absence of 85=kD proteins phosphorylated 
on tyrosine residues in the PI=3 kinase precipitates from both 
Fc~RIIIAot/3`z and Fc3`RIIIAc~/~'2 expressing T  cells, and 
the observation that this subunit, precipitated from [3zp]_ 
labded, nonstimulated or stimulated NK cells, has similar 
levels of phosphorylation argue against the possibility that 
phosphorylation of the regulatory subunit of PI-3 kinase occurs 
upon Fc~KIII cross-linking. Thus, activation of the kinase 
upon Fc3`RIII stimulation does not correlate with its tyro- 
sine phosphorylation and,  as proposed in  other receptor 
systems, is likely to occur upon its association  with phos- 
photyrosine residues on other proteins (38). PI=3 kinase acti= 
ration is indeed observed in vitro upon binding of phosphopep= 
tides to the SH2 domains of the 85-kD subunit (39,  40). 
This, in turn, may induce structural modifications that are 
transmitted to the associated 110-kD subunit and may regu- 
late PI=3 kinase enzymatic activity via an allosteric mecha- 
nism (18, 39). 
PI=3 kinase activation occurred independently of the type 
of accessory chain (3' or ~  associated with Fc3`KIIIA. How= 
ever, quantitative differences were observed in the levels of 
in vitro kinase activity between the Fc3`RIIIA/~'2 and the 
NK cells and Fc3`RIIIA/3'2  transfectants.  The possibility 
that the two call lines  used for transfeetion (the parental 
CD3 + and its CD3-  mutant) differ in essential aspects of 
signal transduction is unlikely, because both express similar 
levels of surface Fc3rRIII, which mediate the same early acti= 
￿9  cation events upon stimulation (4, 11, and data not shown). 
Moreover, stimulation of CD3, associated with the endoge- 
nous ~" chain in the Fc3`RIII/3'z transfectants, results in levels 
of PI-3 kinase activity in vitro similar to those detected upon 
CD16 stimulation in the F~RIIIA/~'z transfectants. A more 
likely explanation takes into consideration that both 3' and 
~" chain contain conserved sequences (antigen receptor ho- 
mology 1  [ARH1]  motifs),  common to  other  receptor- 
associated signal=transducing  molecules in several lympho= 
cyte receptor systems, that play a role in coupling the receptors 
with other molecules essential  in the signal transduction 
pathways (41, 42).  Three ARH1  motifs are present in ~', 
whereas only one is present in the 3" chain. Such motifs are 
sites of interaction with tyrosine kinases and, possibly, with 
other SH2 domains-containing proteins. No formal proof 
exists of a direct correlation with, or dependence on, these 
motifs for the 3, and ~" chains association with tyrosine ki- 
nases. However, this possibility is suggested by the observa- 
tion that copreeipitation of p56  kk with truncated ~" chain ex= 
pressing only one or two ARH1 motifs is decreased (15). 
The type of the receptor=assodated  chain, as in the case of 
the two transfeetants analyzed, may dictate quantitative differ- 
ences in phosphorylation of proteins that associate physically 
and/or functionally with PI-3 kinase after receptor stimulation. 
In several receptor systems, induction of PI=3 kinase ac- 
tivity in the tyrosine phosphorylated proteins pool in vitro 
correlates with activation of the enzyme in the intact cells 
and subsequent accumulation olD=3 phosphoinositides (23, 
35).  In agreement with this,  significant  levels of PI-3-P1, 
PI=3,4=Pz, and high levels of PI-3,4,5-P3,  were detected in 
Fc3`RIIIAod  ~'2 transfected cells treated with anti-CD16, but 
not control anti=CD56 antibodies. Low, but detectable levels 
of PI-3,4,5-P3 were accumulated in Fc3`KIIIAcd3`z=expres- 
sing T cells, which were similar to those detected after CD3 
stimulation. The observation that the levels of PI=3,4,5-P3 
induced via CD3 (associated with the endogenous ~" chain) 
are lower than those induced via CD16 in the Fc3,KIIIA/~'2 
transfectants is compatible with data in primary T cells, in- 
dicating that activation of the TCR-CD3 complex and of 
CD2 antigen results in small increases of PI-3,4=P2 and PI=3, 
4,5=P3 (31), and suggests that differences in the molecular 
complexes formed by the Fc3`KIIIA and TCR-CD3 with 
the ~" chain may result in quantitative differences in the signal 
transduction events. The different levels of D3=lipids detected 
in the 3, and ~" transfected T cells may depend on the mecha- 
nisms discussed above for the in vitro detected activation of 
PI-3 kinase. In NK cells, where we could not detect significant 
increase in D=3 lipids at any time point tested after Fc3`ILIIIA 
stimulation, a lower efl~dency of the Fc3`KIIIA/3`2 molec- 
ular complexes, that constitute the majority of the receptors 
(28), to activate the kinase may be responsible for the di~culty 
in detecting D-3 products, analogous to the situation with 
the Fc3`RIIIA/3`2 transfectants.  Alternatively, and in addi- 
tion, phosphatases may be activated in NK cells upon Fc3,R 
stimulation, that quickly dephosphorylate the lipids or inac- 
tivate the kinase by reducing its association with tyrosine phos- 
phorylated proteins. The significance of a dissociation between 
induced PI=3 kinase activity detectable in vitro and detection 
of its products in intact cells is unknown, but examples of 
it exist: e.g., epidermal growth factor stimulation results in 
accumulation of the PI-3 kinase products in NA1 Leydig tumor 
cells (43), but not in A431 cells (26, 44),  whereas in both 
cell types PI=3 kinase activation is detected in vitro upon 
receptor stimulation. 
Although a  correlation between kinase activation  and 
specific functional effects can not be established  at present, 
the Fc3`KIIIA=induced association of PI-3 kinase with tyro- 
sine phosphorylated proteins and its consequent activation 
point to a role for this kinase in Fc3`RIII=mediated signal 
transduction. 
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